ADAR1 的非编辑功能在巨噬细胞激活和腹主动脉瘤中的作用。
ADAR1 Non-Editing Function in Macrophage Activation and Abdominal Aortic Aneurysm.
机构信息
Departments of Surgery (D.C., T.M., X.Q., S.-Y.C.), University of Missouri School of Medicine, Columbia.
Department of Physiology and Pharmacology, University of Georgia, Athens (C.S.).
出版信息
Circ Res. 2023 Feb 17;132(4):e78-e93. doi: 10.1161/CIRCRESAHA.122.321722. Epub 2023 Jan 23.
BACKGROUND
Macrophage activation plays a critical role in abdominal aortic aneurysm (AAA) development. However, molecular mechanisms controlling macrophage activation and vascular inflammation in AAA remain largely unknown. The objective of the study was to identify novel mechanisms underlying adenosine deaminase acting on RNA (ADAR1) function in macrophage activation and AAA formation.
METHODS
Aortic transplantation was conducted to determine the importance of nonvascular ADAR1 in AAA development/dissection. Ang II (Angiotensin II) infusion of ApoE-/- mouse model combined with macrophage-specific knockout of ADAR1 was used to study ADAR1 macrophage-specific role in AAA formation/dissection. The relevance of macrophage ADAR1 to human AAA was examined using human aneurysm specimens. Moreover, a novel humanized AAA model was established to test the role of human macrophages in aneurysm formation in human arteries.
RESULTS
Allograft transplantation of wild-type abdominal aortas to ADAR1+/- recipient mice significantly attenuated AAA formation, suggesting that nonvascular ADAR1 is essential for AAA development. ADAR1 deficiency in hematopoietic cells decreased the prevalence and severity of AAA while inhibited macrophage infiltration and aorta wall inflammation. ADAR1 deletion blocked the classic macrophage activation, diminished NF-κB (nuclear factor kappa B) signaling, and enhanced the expression of a number of anti-inflammatory microRNAs. Mechanistically, ADAR1 interacted with Drosha to promote its degradation, which attenuated Drosha-DGCR8 (DiGeorge syndrome critical region 8) interaction, and consequently inhibited pri- to pre-microRNA processing of microRNAs targeting IKKβ, resulting in an increased IKKβ (inhibitor of nuclear factor kappa-B) expression and enhanced NF-κB signaling. Significantly, ADAR1 was induced in macrophages and interacted with Drosha in human AAA lesions. Reconstitution of ADAR1-deficient, but not the wild type, human monocytes to immunodeficient mice blocked the aneurysm formation in transplanted human arteries.
CONCLUSIONS
Macrophage ADAR1 promotes aneurysm formation in both mouse and human arteries through a novel mechanism, that is, Drosha protein degradation, which inhibits the processing of microRNAs targeting NF-kB signaling and thus elicits macrophage-mediated vascular inflammation in AAA.
背景
巨噬细胞激活在腹主动脉瘤(AAA)的发展中起着关键作用。然而,控制 AAA 中巨噬细胞激活和血管炎症的分子机制在很大程度上仍不清楚。本研究的目的是确定腺苷脱氨酶作用于 RNA(ADAR1)在巨噬细胞激活和 AAA 形成中的作用的新机制。
方法
进行主动脉移植以确定非血管 ADAR1 在 AAA 发展/夹层中的重要性。使用 ApoE-/- 小鼠模型的 Ang II(血管紧张素 II)输注结合巨噬细胞特异性 ADAR1 敲除来研究 ADAR1 在 AAA 形成/夹层中的巨噬细胞特异性作用。使用人类动脉瘤标本研究巨噬细胞 ADAR1 与人类 AAA 的相关性。此外,建立了一种新的人类化 AAA 模型,以测试人类巨噬细胞在人类动脉中形成动脉瘤的作用。
结果
野生型腹部主动脉同种异体移植到 ADAR1+/-受体小鼠中显著减轻了 AAA 的形成,表明非血管 ADAR1 是 AAA 发展所必需的。造血细胞中 ADAR1 的缺失减少了 AAA 的发生率和严重程度,同时抑制了巨噬细胞浸润和主动脉壁炎症。ADAR1 缺失阻断了经典的巨噬细胞激活,减少了 NF-κB(核因子 kappa B)信号,并增强了许多抗炎 microRNA 的表达。在机制上,ADAR1 与 Drosha 相互作用以促进其降解,从而减弱了 Drosha-DGCR8(DiGeorge 综合征关键区域 8)相互作用,进而抑制了靶向 IKKβ 的 microRNA 的前体到前 microRNA 加工,导致 IKKβ(核因子 kappa-B 的抑制剂)表达增加和 NF-κB 信号增强。重要的是,ADAR1 在人类 AAA 病变中的巨噬细胞中被诱导,并与 Drosha 相互作用。将 ADAR1 缺陷但不是野生型的人类单核细胞重建到免疫缺陷小鼠中,阻止了移植的人类动脉中的动脉瘤形成。
结论
巨噬细胞 ADAR1 通过一种新的机制,即 Drosha 蛋白降解,促进了在小鼠和人类动脉中的动脉瘤形成,该机制抑制了靶向 NF-kB 信号的 microRNA 的加工,从而引发 AAA 中的巨噬细胞介导的血管炎症。